A number of conditions, and their interaction, are essential to the translation and innovation process across sectors. Policy interventions can support innovation but evidence of their effectiveness is currently limited.
RAND researchers identified best practices for engaging participants in the All of Us Research Program, which collects long-term health data from 1 million U.S. adults. Engagement involves awareness, enrollment, and retention of program participants.
In 2009, RAND Europe conducted a literature review to assess the effectiveness and efficiency of peer review for grant funding. This report updates that review and adds case studies exploring peer review practice at six international funders.
This study explores the contribution of the Small Business Research Initiative (SBRI) Healthcare programme to innovation in the NHS (National Health Service). It was commissioned by the UK Department of Health Policy Research Programme.
The pilot demonstrated not only the usefulness of examining the impact of research from the perspectives of a range of stakeholders but also, notably, the extent and variety of the benefits that accrue from research.
Expected increases in life expectancy together with increasingly complex physical and mental illness will continue to exert huge pressures on health systems. How should the UK prepare for the challenges ahead?
The nation's public umbilical cord blood banks provide benefits that far outweigh their costs and should continue to receive federal support, even though use of cord blood stem cells from the banks has been declining.
U.S. umbilical cord blood banks provide benefits that far outweigh their costs. The national cord blood system should continue to receive federal support, even though use of cord blood stem cells from the banks has been declining.
RAND studied trends affecting public cord blood banks and considered changes to the program to buttress banks' financial stability. Researchers found a system worthy of investment, especially if it helps improve the quality of the national inventory.
The report presents findings from a survey conducted by RAND Europe at the request of the National Institute for Health Research to gather and synthesise stakeholder views on the future of health and healthcare in England in 20 to 30 years' time.
The Office of Health Economics and RAND Europe were commissioned by the Oxford BRC to undertake a programme of top-down evaluations of aspects of the impact of the BRC. This programme of research has looked at the health, economic and scientific impact of Oxford BRC's research activity.
Publicly funded biomedical and health research is expected to achieve the best return possible for taxpayers and for society generally. It is therefore important to know whether such research is more productive if concentrated into a small number of 'research groups' or dispersed across many.
Biomedical research can have impacts on patient care at research-active hospitals. We qualitatively evaluated the impact of the Oxford Biomedical Research Centre (Oxford BRC), a university-hospital partnership, on the effectiveness and efficiency of healthcare in local hospitals.